SCHEMBL30906349

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.57

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	RXFP1	Q9HBX9	9/20	0.57

▸	PTH1R	Q03431	7/20	0.54

▸	CCKBR	P32239	1/20	0.50

▸	GLP1R	P43220	1/20	0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30159188	0.93	PTH1R (0.57)	RXFP1PTH1RCCKBRGLP1R
SCHEMBL30433492	0.91	PTH1R (0.57)	RXFP1PTH1RCCKBRGLP1R
SCHEMBL31182832	0.91	RXFP1 (0.61)	RXFP1PTH1RCCKBRGLP1R
SCHEMBL30159127	0.90	RXFP1 (0.54)	RXFP1PTH1RCCKBRGLP1R
SCHEMBL31174218	0.90	RXFP1 (0.59)	RXFP1PTH1RCCKBRGLP1R
SCHEMBL30159324	0.90	BACE1 (0.56)	RXFP1PTH1RGLP1R
SCHEMBL30432112	0.89	RXFP1 (0.60)	RXFP1PTH1RCCKBRGLP1R
SCHEMBL30159280	0.88	BACE1 (0.54)	RXFP1PTH1RGLP1R
SCHEMBL29677427	0.87	RXFP1 (0.53)	RXFP1PTH1R
SCHEMBL30437160	0.87	BACE1 (0.56)	RXFP1PTH1RCCKBRGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed